Haim Werner
Tel Aviv University
H-index: 65
Asia-Israel
Top articles of Haim Werner
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
982 IGF1R inhibition effect on TTFields treated epithelial ovarian cancer | Lior Gal Haber Shilhav Meisel Sharon Mordechai Hallak Haim Werner Ilan Bruchim | 2024/3/1 | |
New therapeutic targets for endometrial cancer: a glimpse into the preclinical sphere. | Ilan Bruchim Ilaria Capasso Ariel Polonsky Shilhav Meisel Vanda Salutari | 2024/2/9 | |
PR052/# 439 Distinct vaginal microbiome ovarian cancer patients–a possible screening and prognostic biomarker? | Ronli Hershkovitch Neiterman Lina Salman Shilhav Meisel-Sharon Tomer Bar Noy Renat Reens Carmel | 2023/11/1 | |
Congenital IGF-1 deficiency protects from cancer: Lessons from Laron syndrome | Zvi Laron Haim Werner | 2023/9/1 | |
Insulin-like growth factors and aging: Lessons from Laron syndrome | Haim Werner Zvi Laron | 2023/10/24 | |
Administration of insulin like growth factor I (IGFI) lowers serum lipoprotein (a)-impact on atherosclerotic cardiovascular disease | Zvi Laron Haim Werner | 2023/7/22 | |
The IGF1 signaling pathway: from basic concepts to therapeutic opportunities | Haim Werner | 2023/10/4 | |
Lessons from Laron syndrome | Endocrine Abstracts | Haim Werner | 2023/5/2 |
# 321 Combination of IGF1R inhibition with PD-1 blockade results in significant anti-tumoral activity in epithelial ovarian cancer | Shilhav Meisel-Sharon Lina Somri-Gannam Shay Hantisteanu Hallak Mordechai Haim Werner | 2023/9/1 | |
New Insights into the Role of the Insulin-Like Growth Factors in Breast Cancer | Haim Werner | 2023/4/24 | |
DNA damage response pathways meet endocrine systems | Frontiers in Endocrinology | Haim Werner Leonard Girnita | 2023/1/27 |
EP227/# 389 Combination of IGF1R inhibition with PD-1 blockade results in significant anti-tumoral activity in epithelial ovarian cancer | Lina Somri-Gannam Shilhav Meisel-Sharon Shay Hantisteanu Mordechai Hallak Haim Werner | 2023/11/1 | |
# 348 The BCAM-AKT2 fusion protein effect on the IGF1 signaling pathway in epithelial ovarian cancer cells | Hala Khazem Shilhav meisel Sharon Shay Hantisteanu Mordechai Hallak Haim Werner | 2023/9/1 | |
EP223/# 762 Distinct vaginal microbiome in newly diagnosed ovarian cancer patients | Ronli Hershkovitch Neiterman Lina Salman Shilhav Meisel Sharon Shay Hantisteanu Raphy Zarecki | 2022/12/1 | |
Toward gene therapy of Laron syndrome | Gene Therapy | Haim Werner | 2022/6 |
EP208/# 677 Combination of IGF1R inhibition with PD-1 blockade results in significant anti-tumoral activity in epithelial ovarian cancer | International Journal of Gynecological Cancer | Lina Somri-Gannam Shilhav Meisel Sharon Shay Hantisteanu Hallak Mordechai Haim Werner | 2022/12/1 |
Identification of UDP-Glucuronosyltransferase 2B15 (UGT2B15) as a Target for IGF1 and Insulin Action | Cells | Rive Sarfstein Karthik Nagaraj Shivang Parikh Carmit Levy Zvi Laron | 2022/5/12 |
BRCA1: an endocrine and metabolic regulator | Haim Werner | 2022/3/31 | |
EP209/# 686 BCAM-AKT2 fusion protein and the IGF1 signaling pathway in epithelial ovarian cancer | International Journal of Gynecological Cancer | Hala Khazem Dvir Reder Shilhav Meisel Sharon Shay Hantisteanu Hallak Mordechai | 2022/12/1 |
Hallmarks of cancer: The insulin-like growth factors perspective | Haim Werner Derek LeRoith | 2022/11/21 |
Co-Authors
